Scott Claunch

Affiliation

TerraPower, LLC

Biography

Scott Claunch is president of TerraPower Isotopes®, a division of TerraPower focused on the pursuit of next-generation therapeutic medical isotopes for Targeted Alpha Therapy (TAT) treatments. In this role, Claunch guides the business in the strategy, processing and delivery of select materials and grows the industry and innovator partnerships necessary to develop and commercialize TAT treatments to potentially eliminate many forms of cancer. Prior to joining TerraPower, Claunch led the Global Nuclear Medicine Franchise at Lantheus Medical Imaging. He was responsible for commercial sales for all nuclear medicine products and pre-launch activities for Lantheus’ future portfolio in Positron Emission Tomography (PET). Additionally, he oversaw cyclotron operations used in the